Outset Medical to Present at Upcoming Investor Conferences

Rhea-AI Summary

Outset Medical, Inc. (Nasdaq: OM) announced management participation in two investor conferences. The Stifel 2022 Healthcare Conference is set for November 15, 2022, at 5:35am PT. The Jefferies London Healthcare Conference follows on November 17, 2022, at 5:55am PT. Both sessions will be accessible via live and archived webcasts on the Outset website. Outset is known for its innovative Tablo Hemodialysis System, which simplifies dialysis cost and complexity, enhancing patient care from hospitals to home.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in fireside chats at two upcoming investor conferences. Outset will participate in the Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022, and the Jefferies London Healthcare Conference on Thursday, November 17, 2022.

Event: Stifel 2022 Healthcare Conference
Date: Tuesday, November 15, 2022
Time: 5:35am PT / 8:35am ET

Event: Jefferies London Healthcare Conference
Date: Thursday, November 17, 2022
Time: 5:55am PT / 8:55am ET / 12:55pm GMT

Live and archived webcasts of the fireside chats will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005093/en/

Jim Mazzola

Vice President, Investor Relations

jmazzola@outsetmedical.com

Brian Johnston

Gilmartin Group

(332) 895-3222

investors@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

When will Outset Medical participate in the Stifel 2022 Healthcare Conference?

Outset Medical will participate in the Stifel 2022 Healthcare Conference on November 15, 2022, at 5:35am PT.

What is the date and time of the Jefferies London Healthcare Conference for Outset Medical?

The Jefferies London Healthcare Conference will take place on November 17, 2022, at 5:55am PT.

Where can I watch the webcasts of Outset Medical's fireside chats?

The webcasts will be available live and archived on the Investors section of Outset Medical's website.

What technology does Outset Medical offer for dialysis?

Outset Medical offers the Tablo Hemodialysis System, a pioneering technology that reduces the cost and complexity of dialysis.

What advantage does the Tablo Hemodialysis System provide?

Tablo provides a single enterprise solution for delivering dialysis anytime, anywhere, simplifying operations and enhancing patient care.